Immediate Impact
4 by Nobel laureates 38 from Science/Nature 71 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1
2023 StandoutScience
Works of Michael Hubalek being referenced
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
2021
hCDC4 gene mutations in endometrial cancer.
2002
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Hubalek | 1023 | 370 | 458 | 641 | 70 | 1.9k | |
| Xiaoling Liu | 943 | 228 | 277 | 838 | 57 | 1.9k | |
| Lei Fan | 907 | 241 | 610 | 589 | 57 | 2.1k | |
| Anette Sommer | 690 | 187 | 317 | 1202 | 62 | 2.0k | |
| Volker Möbus | 1176 | 307 | 574 | 484 | 115 | 2.1k | |
| Khalil Helou | 486 | 290 | 504 | 1201 | 112 | 2.1k | |
| Anneke Geurts‐Moespot | 518 | 227 | 525 | 791 | 75 | 2.8k | |
| Paola Ferrari | 807 | 332 | 480 | 924 | 101 | 2.5k | |
| Danijela Jelovac | 902 | 289 | 460 | 905 | 47 | 2.1k | |
| Laura Pizzuti | 879 | 326 | 398 | 446 | 96 | 1.6k | |
| Michael Schrauder | 726 | 247 | 961 | 836 | 62 | 2.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...